Bigul

Supriya Lifescience Ltd - 543434 - Announcement under Regulation 30 (LODR)-Newspaper Publication

Please find enclosed herewith Newspaper Publication.
04-08-2023
Bigul

Supriya Lifescience Ltd - 543434 - Audio Recording Of Earnings Call

Please find enclosed audio recording of Earning Call.
04-08-2023
Bigul

Supriya Lifescience Ltd - 543434 - Statement Of Deviation Or Variation In The Use Of Proceeds Of The Fresh Issue Of The Initial Public Offer Of The Company

Please find enclosed herewith Statement of Deviation report for the quarter ended June 30, 2023.
04-08-2023
Bigul

Supriya Lifescience Ltd - 543434 - Announcement under Regulation 30 (LODR)-Investor Presentation

Please find attached herewith Investor Presentation.
03-08-2023
Bigul

Supriya Lifescience Ltd - 543434 - Unaudited Financial Results For The Quarter Ended June 30, 2023

Enclosing Unaudited Financial Results for the quarter ended June 30, 2023.
03-08-2023
Bigul

Supriya Lifescience Ltd - 543434 - Board Meeting Outcome for Outcome Of Board Meeting In Accordance With SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

Pursuant to Regulation 33 read with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please be informed that the Board of Directors of the Company at its Meeting held on Thursday, August 3, 2023, inter-alia, has considered and approved the Unaudited Financial Results for the Quarter ended June 30, 2023. We hereby enclose the following: 1. Copy of the Unaudited Financial Results of the Company for the quarter ended June 30, 2023 along with the Limited Review report issued by Statutory Auditor;
03-08-2023
Bigul

Supriya Lifescience shares rise post tie-up with US-based Plasma Nutrition

Supriya Lifescience partners with US-based Plasma Nutrition for ioProtein launch in India
03-08-2023
Next Page
Close

Let's Open Free Demat Account